This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). 1 The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients. Sign up today for our free Drug Topics newsletter.
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. million adult patients who were enrolled in a health plan as of January 2022 that contributed data to the Optum database. Of those, 38% had evidence of pneumococcal vaccination prior to January 2022.
In 2022, the estimated cost of those diagnosed as having diabetes was $413 billion. 2022 Jun 20;15:1911-1923. Additional advantages include fewer emergency visits, hospitalizations, medication adherence, and associated cost savings. 2 “Prevalence of diabetes in the United States continues to rise, affecting an estimated 38.4
Food and Drug Administration (FDA), such as Rybelsus (oral semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), and Saxenda (liraglutide). Compounded semaglutide is another option, and its lower cost may make it seem like an appealing alternative. What are compounding pharmacies?
Updated September 12, 2022. June 20 to 23, 2025. Chicago, Illinois. Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD). ClinicalTrials.gov identification: NCT04161131. Accessed June 23, 2025.
Daymon, 2022 Private Brand Intelligence Report, May 2023. Our team will be on site to share insights and showcase our portfolio of more than 500 health and wellness OTC products through the Foster & Thrive brand name, including affordable and eco-friendly offerings that reflect today’s consumer priorities. Fred Reichheld. April 2025.
Mounjaro (tirzepatide) is a brand-name prescription medication that is approved by the Food and Drug Administration (FDA) to improve blood sugar levels in people with Type 2 diabetes. The FDA recently approved generic versions of two other GLP-1s , Victoza (liraglutide) and Byetta (exenatide). Is there a generic for Mounjaro?
Drug manufacturer Novo Nordisk produces it under the brand name Rybelsus , and the FDA approved it for managing blood glucose in people with Type 2 diabetes but not Type 1 diabetes. Some compounding pharmacies might make semaglutide tablets themselves, but these drugs arent FDA-approved or inspected. mg dose once weekly.
According to 2022 data from a National Health Interview Survey of US adults ages 18 and older, just 23.0% Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Despite their purported efficacy and safety, uptake remains below target levels. Last Updated October 26, 2024. Accessed July 23, 2025.
In fact, its kind of a jack-of-all-trades drug, approved by the Food and Drug Administration (FDA) to treat epilepsy, postherpetic neuralgia, and restless leg syndrome. Avoid alcohol: Drinking alcohol can cause central nervous system side effects like dizziness and drowsiness, which might compound gabapentins effects.
Image Credit: Elena | stock.adobe.com A 2022 study reported that approximately 90% of the United States population lives within 5 miles of a pharmacy. Compounding this issue, many pharmacies face ongoing staffing shortages, which hinder efficient operations and compromise the ability to deliver quality patient care.
November 7, 2022. American Pharmacists Association. Accessed May 29, 2025. link] Disparities in flu vaccination coverage are cause for concern. National Foundation for Infectious Diseases. Accessed May 29, 2025.
Study Overview Researchers conducted a retrospective chart review of 80 patients aged 12 or older within Intermountain Health who were diagnosed with asthma between December 2022 and December 2023. To ensure continuity of care, patients included had seen a primary care provider both in the year prior to and following their diagnosis.
December 2022. News release. Oregon Health and Science University. May 9, 2019. Accessed July 11, 2025. Arkansas Maternal Mortality Review Committee. Legislative Report. Accessed July 11, 2025. Koonin LM, Patel A. Timely antiviral administration during an influenza pandemic: key components. Am J Public Health. 2018;108(Suppl 3):S215-S220.
Its average fiscal year 2022 readmission rate was 23.7%, exceeding the 19.6% The hospital-approved protocol, created in June 2022, granted TOC pharmacists prescribing authority for guideline-directed medical therapy (GDMT), consisting of a 30-day supply of rescue and triple-therapy inhalers, at discharge for patients with AECOPD.
May 4, 2022. Isatuximab shows promise in enhancing PFS for patients with multiple myeloma. Pharmacy Times. August 8, 2024. Accessed July 8, 2025. Multiple myeloma. Cleveland Clinic. Accessed July 8, 2025.
A new drug application for lorundrostat is expected to be filed with the FDA in 2025. Lancet 2022; 400:1927-1937. The most frequent dose limiting adverse effect is hyperkalemia which is dose-related with an incidence of 5% to 7%. mg/d, 1 mg/d, 2 mg/d, and placebo for 12 weeks. 17 The placebo-subtracted reductions in sBP were 8.1
The trial was conducted from January 2021 to December 2022, with a feedback letter sent on or after January 2022, including physicians that were randomly assigned in a 4 to 1 allocation. The misuse and overuse of antimicrobials to treat, prevent, and control infections has influenced the spread of AMR.
Updated September 21, 2022. Centers for Disease Control and Prevention. Accessed March 5, 2025. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
The Orange Book is the reference, and it allows the FDA to declare something [to be] therapeutically equivalent. The FDA Approval Process Within the FDA approval process, the 505(b)(1) new drug application (NDA) submission pathway is the pathway by which new drugs are able to seek approval.
On February 21, 2020, the FDA approved eptinezumab-jjmr (Vyepti; Lundbeck) as the first intravenous migraine preventative treatment for adults. Clinical trials showed eptinezumab-jjmr's efficacy in reducing migraine days and acute medication use, with benefits emerging within 24 hours.
FDA approval of LIMITX for broader use could significantly impact opioid misuse prevention and save lives. Or, as FDA officials like to call it, “multiple tablet ingestion”—I guess it sounds better to them. trillion economic impact in 2020. SHOW MORE A novel solution can strategically control the release of the drug in vivo.
link] 2022 global strategy for prevention, diagnosis, and management of COPD. Updated 2022. Lancet Respir Med.2022;10(5):447-458. 2022;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7 Global strategy for asthma management and prevention. Accessed June 6,2025. Global Initiative for Asthma. Accessed June 6, 2025. 2023;17:259-272.
1,2 To better understand this relationship, researchers assessed 4754 patients with CLL/SLL who were treated with either venetoclax and obinutuzumab from April 2016 to August 2022 (n = 2104) or zanubrutinib from November 2019 to August 2023 (n = 2650).
2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025. Development Trends: Oncology at the Forefront Gene therapy currently ranks third among therapeutic focus areas, with 2151 compounds in development in 2024 ( Figure ).
1 Vesicular monoamine transporter type 2 (VMAT2) inhibitors are the only FDA-approved treatment options. 6 A third VMAT2 inhibitor, tetrabenazine (Xenazine; Lundbeck Pharmaceuticals LLC), is also on the market but is only FDA approved for the treatment of Huntington disease (HD) chorea.
Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Admin Pharm. 2020;16(9):1155-1165. doi:10.1016/j.sapharm.2019.12.016 2019.12.016 3. ASHP Statement on Professionalism. American Society of Health-System Pharmacists. Accessed June 9, 2025.
SHOW MORE Hulio shows comparable efficacy and safety to Humira in treating chronic plaque psoriasis, supporting its FDA interchangeability status. The authors noted that these results support the FDA-granted interchangeability status of Hulio.
Semi-synthetic opioids are scientifically modified versions of these naturally occurring compounds. The Food and Drug Administration (FDA) has approved certain opioids for: Relief of mild to moderate severe pain (e.g., The Food and Drug Administration (FDA) has approved certain opioids for: Relief of mild to moderate severe pain (e.g.,
Medication Adherence Requires Personalized Communication Alva emphasized that effective counseling about medications—especially those with intimidating FDA warnings—requires compassionate, patient-centered communication.
Another notable detail from this study was that tirzepatide wasn’t FDA-approved until 2022, midway through the study period, possibly owing much of the GLP-1 benefits to semaglutide rather than tirzepatide.
OTC Use Saves Billions From Cost-Effective Products and Encounters Image credit: Amina | stock.adobe.com A 2022 publication purported $167 billion in savings in ancillary health care cost avoidance through the widespread use of OTC products in the United States. November 2022. REFERENCES The power of OTCs to provide consumer value.
1 Image credit: Cynthia | stock.adobe.com The discussion featured Vivian Fonseca, MD, of the Tulane University School of Medicine, who presented an overview of tirzepatide based on the FDA-approved label and clinical guidelines. He was joined by Laura, a patient who began tirzepatide treatment shortly after being diagnosed with T2D.
Mitomycin intravesical solution (Zusduri, UroGen Pharma) was approved by the FDA for treatment of adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).
Updated October 6, 2022. FDA approves ropeginterferon alfa-2b-njft for polycythemia vera. REFERENCES 1. Ropeginterferon alfa 2b for early myelofibrosis. Accessed June 30, 2025. ASCO 2025 delivers insights into future of myelofibrosis care. Pharmacy Times. June 3, 2025. Accessed June 30, 2025. November 12, 2021.
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). American Behavioral Research Institute Boca Raton, Fla. – Amish Origins Management Worland, Wy. –
North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. July 1, 2024. Accessed June 6, 2025. National Association of Boards of Pharmacy. January 21, 2025. Accessed June 6, 2025.
Reviewing Medication Adherence According to the WeAllCount Census for 2022 to 2023, 6 homelessness in San Diego increased by 22% (from 8427 to 10,264 individuals).
SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patient care. The FDA has granted fast track designation to TRE-515 (Trethera Corporation), a novel drug, in combination with radiation therapy for the treatment of prostate cancer.
Biden’s 2022 Inflation Reduction Act (IRA), creating an out-of-pocket spending cap of $2000 starting in 2025, and Part D has become a very generous pharmacy benefit. A 2024 RAND study using 2022 data found that among Organisation for Economic Co-operation and Development (OECD) countries (comparably developed nations), the US paid 4.22
In May 2024, the US Food and Drug Administration (FDA) approved Moderna’s next-generation base-modified mRNA-lipid nanoparticle (LNP) respiratory syncytial virus (RSV) vaccine mRESVIA (mRNA-1345) in adults aged 60 years and older with lower respiratory tract disease (5). billion by 2034, exhibiting a compound average growth rate of 1.2%
The FDA has approved lenacapavir (Yeztugo; Gilead Sciences), a twice-yearly injectable HIV-1 capsid inhibitor, for the prevention of HIV as preexposure prophylaxis (PrEP), according to reports from NBC News, USA Today, and CNBC and a news release from Gilead Sciences.
The FDA plans to remove concentrated fluoride prescription products due to toxicity and neurocognitive concerns. 7 On May 13, 2025, the FDA issued a news release indicating it is taking action to remove concentrated fluoride prescription drug products from the market.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content